When your talking sales to the Philippines. Unless
Post# of 148168
I see this effort to stock the hospitals as not the best way to produce sales. We want the government to buy for all the people. As it is now, the wealthy and the connected government officials will benefit but what about the whole country of people? This will be an out of pocket expense for those that can afford the dose. Insurance doesn’t pay for experimental drugs here. Why would they in the Philippines? Do they have a socialized medicine all free system? Still probably won’t approve our doses without an EUA approval if they are socialized. This looks to be counter productive for sales on one side. Being that if the wealthy and the government official can get their doses what is the hurry to approve it for everyone else?
I see this as an experiment at best with wealthy people footing the Bill of our somewhat of a trial by the Philippines FDA working the CSP as we used our EIND. I want to see the positives in all of this but where are the positives? I love that we help people get Leronlimab so they can live and I hope this turns into a worthy USA FDA protocol approved trial for us. That’s the best case scenario to me. Faster filling of a approved protocol trial.
Maybe someone can point out an expected timeline of how this is suppose to work out for us? With expectations other than what I have mentioned. See a better path forward? Seems to me that the general population of the Philippines is on the lower income as a nation and could not afford to get doses of Leronlimab out of their own pockets. I hope things happen quickly for them and if an EUA approval happens quickly that all people of all incomes can get the doses. Not just the wealthy and connected. Can someone give me their version of how this whole adventure progresses for the good of both the Philippine people and for the sales of our company? My view is a little clouded right now.